| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Common Stock | Award | $97,500 | +150,000 | +50% | $0.6500 | 448,535 | 06 Oct 2023 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MOBQ | Common Stock | Award | $300,000 | 524,671 | 06 Oct 2023 | Common Stock | 428,571 | $0.7000 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | The 448,535 common shares includes shares owned directly by Dr. Salkind, the doctor and his wife and through a trust in which Dr. Salkind is the trustee. |
| F2 | The derivative securities listed in Table II are derivative securities owned directly by Dr. Salkind and his wife and by the trust. Salkind has the right to convert $300,000 loan into common stock at $.70 per share or into the terms of a financing completed before November 30, 2023. |
| F3 | Not applicable. |